Last updated: August 22, 2025
Introduction
Denmark Patent DK3310364 pertains to a pharmaceutical invention that claims innovations in drug formulation, delivery, or therapeutic application. Such patents often aim to extend exclusivity, prevent generic competition, or secure licensing revenues. Understanding DK3310364’s scope, claims, and its position within the patent landscape provides essential insights for stakeholders, from pharmaceutical companies to generic drug manufacturers.
This analysis covers the patent's scope, the breadth and limitations of its claims, the ophthalmic, chemical, or biologic nature of the invention (if applicable), and its landscape relevance within the global drug patent ecosystem.
Patent Overview and Context
DK3310364 was granted by the Danish Patent Office, representing regional exclusivity typical in the European patent system. While Denmark is part of the European Patent Convention (EPC), patents granted by Denmark primarily serve as enforceable rights within its jurisdiction but can influence broader European or international strategies.
The patent’s application was likely filed initially under the Patent Cooperation Treaty (PCT) or directly filed in Denmark, focusing on a specific drug or formulation innovation. As it stands, DK3310364 exemplifies a drug-related patent, potentially related to novel compounds, formulations, delivery systems, or manufacturing processes.
Scope of the Patent
1. Scope of Protection
The scope of DK3310364 is primarily defined by its claims, which specify the boundaries of the patent’s enforceability. The claims articulate what exclusivity rights the patent holder holds, usually encompassing:
- Active compound(s): The chemical entity, derivatives, salts, or isomers.
- Formulation techniques: Specific drug delivery forms such as sustained-release, nanoparticles, or targeted delivery.
- Method of manufacturing: Processes, conditions, or intermediates.
- Therapeutic uses: Particular medical indications or methods.
The patent’s independent claims establish its core inventive scope, while dependent claims refine and narrow this coverage.
Finding the Claims:
While the complete claims are accessible in the official patent documentation, common types include:
- Composition claims, e.g., "A pharmaceutical composition comprising compound X"
- Use claims, e.g., "Use of compound X for treating disease Y"
- Method claims, e.g., "A method of administering compound X"
- Formulation-specific claims, e.g., "A sustained-release formulation of compound X"
2. Breadth of the Claims
The breadth of DK3310364 hinges on whether it covers a specific compound, a class of compounds, a particular formulation, or a delivery method. Broad claims might encapsulate:
- Chemical diversity: Variants, salts, or isomers of a core compound.
- Delivery systems: Liposomes, microspheres, or polymer-based carriers.
- Therapeutic indications: Specific diseases or conditions.
Narrow claims, conversely, focus on a unique compound or method with limited scope but potentially stronger patent protection.
The scope’s strength depends on the claims' specificity. Overly broad claims risk invalidation if prior art is encountered but provide better market exclusivity. Conversely, narrow claims protect specific embodiments but risk being circumvented by minor modifications.
Key Claim Features and Innovative Aspects
Given the limited public detail in this scenario, typical innovative features in these patents include:
- Novel chemical entities with therapeutic benefits or improved pharmacokinetics.
- Advanced drug delivery systems optimizing bioavailability or patient compliance.
- Manufacturing processes that enhance purity, stability, or reduce costs.
- New therapeutic uses that expand the scope of the drug’s application.
In many cases, the claims combine these elements to carve out a unique niche within existing treatment landscapes.
Patent Landscape Analysis
1. Prior Art and Related Patents
The patent landscape surrounding DK3310364 involves a complex network of prior patents, scientific publications, and patents from competitors. An effective landscape analysis entails:
- Patent family searches to identify related filings in Europe, the US, and other jurisdictions.
- Prior art searches to determine novelty over existing drugs, formulations, or methods.
- Citations analysis, highlighting influential patents or publications.
Likely Related Patent Families:
Possible related patents may involve the original compound, derivatives, or formulations, especially if the patent claims are narrow or specific. Competitors may have filed for similar compounds or delivery systems, creating an intricate web of overlapping protection.
2. Competitive and Legal Positioning
DK3310364’s scope will influence its resilience against challenges and its capacity to block competitors:
- Strong positioning if claims are broad and novel.
- Risk of invalidation if prior art shows similar compounds or formulations.
- Patent fences surrounding related patents may provide freedom-to-operate or necessitate licensing negotiations.
3. Lifecycle and Market Implications
If DK3310364 covers a core innovation, its expiry will impact generics and biosimilars. Its legal strength, scope, and enforceability determine its lifecycle value.
Regulatory and Commercial Considerations
While this article focuses on patent analysis, regulation interplay (FDA, EMA approvals) significantly influences patent strategies. Patents with formulations or uses aligned with regulatory exclusivity can extend market control durations.
Conclusion
DK3310364 exemplifies a focused regional patent within Denmark, likely covering a specific chemical compound, formulation, or therapeutic method. Its claim breadth determines its market and legal strength, with wider claims offering more comprehensive protection but potentially higher invalidation risk.
A strategic approach requires mapping its relation with prior art, related patents, and potential for extension into broader jurisdictions. Its position within the patent landscape impacts licensing, enforcement, and competition strategies.
Key Takeaways
- Well-drafted claims define the core protection; their scope is critical for market exclusivity.
- Prior art analysis is essential to assess patent validity and potential infringement risks.
- Patent landscapes reveal competitive positioning and licensing opportunities.
- Regional patents like DK3310364 influence global strategies but must be evaluated in context with broader patent families.
- Innovation focus—whether on compounds, formulations, or methods—dictates patent strength and lifecycle.
FAQs
1. What type of invention does DK3310364 primarily protect?
While specific claims are needed for certainty, regional patents like DK3310364 generally protect chemical compounds, formulations, or therapeutic methods related to pharmaceutical innovations.
2. How broad are the patent claims typically in Denmark drug patents?
Claim breadth varies; broad claims cover extensive chemical classes or uses but face higher invalidation risks, while narrow claims focus on specific embodiments, offering more targeted protection.
3. Can DK3310364 be enforced outside Denmark?
No, enforcement is limited to Denmark. To effect wider protection, patent rights need to be filed and granted within other jurisdictions, such as through the European Patent Office (EPO) or via national filings.
4. What is the significance of the patent landscape for this patent?
Understanding the landscape helps determine overlapping rights, potential infringement issues, and opportunities for licensing or infringement defenses.
5. When does DK3310364’s patent protection expire?
Typically, patents filed and granted around 2020 in Denmark last for 20 years from the earliest filing date, assuming adherence to maintenance fees. Exact expiry depends on application dates and extensions if applicable.
References
[1] Danish Patent and Trademark Office (DKPTO) Patent Database.
[2] European Patent Office (EPO) Espacenet.
[3] WIPO PatentScope Database.
